Etty Osher

790 total citations
19 papers, 601 citations indexed

About

Etty Osher is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Etty Osher has authored 19 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Physiology. Recurrent topics in Etty Osher's work include Cardiovascular Health and Disease Prevention (4 papers), Mosquito-borne diseases and control (2 papers) and Parathyroid Disorders and Treatments (2 papers). Etty Osher is often cited by papers focused on Cardiovascular Health and Disease Prevention (4 papers), Mosquito-borne diseases and control (2 papers) and Parathyroid Disorders and Treatments (2 papers). Etty Osher collaborates with scholars based in Israel, Germany and Canada. Etty Osher's co-authors include Naftali Stern, Karen Tordjman, Yona Greenman, Galina Shenkerman, Rona Limor, Elena Izkhakov, Marianna Yaron, Ronit Aloni-Grinstein, Meital Charni‐Natan and Varda Rotter and has published in prestigious journals such as Diabetes Care, The American Journal of Medicine and Hypertension.

In The Last Decade

Etty Osher

19 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Etty Osher Israel 14 150 140 131 113 97 19 601
Shi‐Wen Kuo Taiwan 14 301 2.0× 63 0.5× 93 0.7× 189 1.7× 69 0.7× 41 691
Satyesh K. Sinha United States 14 157 1.0× 79 0.6× 132 1.0× 252 2.2× 42 0.4× 25 733
Figen Gürdöl Türkiye 21 128 0.9× 51 0.4× 208 1.6× 156 1.4× 42 0.4× 61 966
Motoaki Komatsu Japan 11 102 0.7× 155 1.1× 167 1.3× 236 2.1× 50 0.5× 28 734
Justin P. Van Beusecum United States 13 162 1.1× 65 0.5× 174 1.3× 261 2.3× 65 0.7× 30 927
Marco Guarneri Italy 16 67 0.4× 181 1.3× 80 0.6× 95 0.8× 34 0.4× 28 638
Marie‐Louise Syrén Italy 17 131 0.9× 238 1.7× 84 0.6× 548 4.8× 44 0.5× 35 929
László Bajnok Hungary 18 237 1.6× 206 1.5× 177 1.4× 254 2.2× 70 0.7× 42 989
Fenping Zheng China 16 199 1.3× 70 0.5× 147 1.1× 273 2.4× 30 0.3× 58 821
Yuzuru Ohshiro Japan 13 184 1.2× 146 1.0× 211 1.6× 238 2.1× 20 0.2× 20 784

Countries citing papers authored by Etty Osher

Since Specialization
Citations

This map shows the geographic impact of Etty Osher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etty Osher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etty Osher more than expected).

Fields of papers citing papers by Etty Osher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etty Osher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etty Osher. The network helps show where Etty Osher may publish in the future.

Co-authorship network of co-authors of Etty Osher

This figure shows the co-authorship network connecting the top 25 collaborators of Etty Osher. A scholar is included among the top collaborators of Etty Osher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etty Osher. Etty Osher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Greenman, Yona, et al.. (2021). Revisiting Cushing Syndrome, Milder Forms Are Now a Common Occurrence: A Single-Center Cohort of 76 Subjects. Endocrine Practice. 27(9). 859–865. 4 indexed citations
2.
Charni‐Natan, Meital, Ronit Aloni-Grinstein, Etty Osher, & Varda Rotter. (2019). Liver and Steroid Hormones—Can a Touch of p53 Make a Difference?. Frontiers in Endocrinology. 10. 374–374. 61 indexed citations
4.
Sofer, Yael, Nava Nevo, Gabi Shefer, et al.. (2017). Human sex hormone-binding globulin does not provide metabolic protection against diet-induced obesity and dysglycemia in mice. Endocrine Connections. 7(1). 91–96. 5 indexed citations
5.
Yaron, Marianna, Elena Izkhakov, Jessica Sack, et al.. (2016). Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors. Pituitary. 19(3). 322–331. 26 indexed citations
6.
Osher, Etty, Aviva Fattal‐Valevski, Leah Peleg, et al.. (2015). Effect of cyclic, low dose pyrimethamine treatment in patients with Late Onset Tay Sachs: an open label, extended pilot study. Orphanet Journal of Rare Diseases. 10(1). 45–45. 30 indexed citations
7.
Stern, Naftali, et al.. (2013). Hyperandrogenism is Associated with Earlier Age of Onset of Idiopathic Intracranial Hypertension in Women. Current Eye Research. 38(9). 972–976. 40 indexed citations
8.
Limor, Rona, Karen Tordjman, Yonit Marcus, et al.. (2011). Serum free cortisol as an ancillary tool in the interpretation of the low-dose 1-μg ACTH test. Clinical Endocrinology. 75(3). 294–300. 13 indexed citations
9.
Tordjman, Karen, Marianna Yaron, Elena Izkhakov, et al.. (2010). Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. European Journal of Endocrinology. 162(5). 925–933. 64 indexed citations
10.
Osher, Etty, Aviva Fattal‐Valevski, Sara Katzburg, et al.. (2010). Pyrimethamine increases β-hexosaminidase A activity in patients with Late Onset Tay Sachs. Molecular Genetics and Metabolism. 102(3). 356–363. 24 indexed citations
11.
Yaron, Marianna, Yona Greenman, Joseph B. Rosenfeld, et al.. (2009). Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men. European Journal of Endocrinology. 160(5). 839–846. 60 indexed citations
12.
Osher, Etty & Naftali Stern. (2009). Obesity in Elderly Subjects. Diabetes Care. 32(suppl_2). S398–S402. 48 indexed citations
13.
Osher, Etty & Naftali Stern. (2008). Diastolic Pressure in Type 2 Diabetes. Diabetes Care. 31(Supplement_2). S249–S254. 12 indexed citations
14.
Stern, Naftali, Etty Osher, & Yona Greenman. (2007). Hypoadiponectinemia as a Marker of Adipocyte Dysfunction—Part I: The Biology of Adiponectin. PubMed. 2(3). 174–182. 15 indexed citations
15.
Stern, Naftali, Etty Osher, & Yona Greenman. (2007). Hypoadiponectinemia as a Marker of Adipocyte Dysfunction—Part II: The Functional Significance of Low Adiponectin Secretion. PubMed. 2(4). 288–294. 23 indexed citations
16.
Greenman, Yona, Rona Limor, Etty Osher, et al.. (2007). Thyroid cysts: a new extra‐adrenal site of aldosterone synthase expression and increased aldosterone content. Clinical Endocrinology. 66(6). 886–889. 5 indexed citations
18.
Osher, Etty, Gary Weisinger, Rona Limor, Karen Tordjman, & Naftali Stern. (2006). The 5 lipoxygenase system in the vasculature: Emerging role in health and disease. Molecular and Cellular Endocrinology. 252(1-2). 201–206. 50 indexed citations
19.
Tordjman, Karen, Yona Greenman, Etty Osher, Galina Shenkerman, & Naftali Stern. (2004). Characterization of normocalcemic primary hyperparathyroidism. The American Journal of Medicine. 117(11). 861–863. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026